# A field polymerizing hydrogel enables simultaneous antimicrobial, hemostatic, and analgesic delivery in traumatic wounds

**Authors:** Elizabeth A. Pumford, Christopher D. Hamad, Amaka I. Enueme, Zeinab Mamouei, Nicholas Peterson, Christopher Hart, Chad Ishmael, Alan Li, Rahul Sobti, Jack Pearce, Jeremiah Taylor, Micah Ralston, Jared D. Wainwright, Kan Nakamoto, Perenlei Enkhbaatar, Kaitlyn A. Cook, Kevin P. Francis, John Adams, Alexandra Stavrakis, Joseph C. Wenke, Andrea M. Kasko, Nicholas M. Bernthal

PMC · DOI: 10.1038/s41598-026-37521-y · Scientific Reports · 2026-02-02

## TL;DR

A new hydrogel dressing can control bleeding, prevent infection, and relieve pain in traumatic wounds, especially in areas with limited medical resources.

## Contribution

A field-polymerizable hydrogel that simultaneously delivers hemostatic, antimicrobial, and analgesic agents in traumatic wounds.

## Key findings

- The hydrogel rapidly polymerizes with water and conforms to irregular wound shapes.
- It showed sustained antibiotic release over four days and eradicated bacterial infections in a murine model.
- Large animal studies confirmed its translational potential for complex wounds.

## Abstract

Traumatic injuries in resource-limited settings, such as remote, rural, or disaster-affected environments, require wound care solutions that can effectively address hemorrhage, infection, and pain outside of traditional clinical infrastructure. We developed a field-polymerizable hydrogel wound dressing capable of delivering tranexamic acid (hemostatic), vancomycin and tobramycin (broad-spectrum antibiotics), and lidocaine (analgesic) directly to the site of injury. Using computational modeling, we designed a lightweight, rugged hydrogel that polymerizes rapidly with potable water and conforms to irregular wound beds. The system demonstrated burst release of hemostatic and analgesic agents and sustained antibiotic release over four days. In vitro and in vivo testing confirmed the hydrogel’s ability to stabilize clots, prevent fibrinolysis, and eradicate polymicrobial gram-positive and gram-negative bacterial infections in a murine model of open fracture. Large animal studies further validated its translational potential in a large, complex wound. This modular, multifunctional platform provides a field-ready solution for wound management in austere environments, with the potential to reduce infection, control bleeding, and improve wound stabilization when access to definitive care is delayed.

The online version contains supplementary material available at 10.1038/s41598-026-37521-y.

## Linked entities

- **Chemicals:** tranexamic acid (PubChem CID 5526), vancomycin (PubChem CID 14969), tobramycin (PubChem CID 36294), lidocaine (PubChem CID 3676)

## Full-text entities

- **Diseases:** traumatic wounds (MESH:D014947)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917186/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917186/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917186/full.md

---
Source: https://tomesphere.com/paper/PMC12917186